
Loading, please wait...

Loading, please wait...

Recent data highlights a significant surge in tobacco consumption in India between 2011 and 2024. Consequently, the Economic Advisory Council to the Prime Minister (EAC-PM) has released a working paper calling for urgent policy interventions. This trend poses serious risks to both individual health and the long-term sustainability of public finances. Therefore, authorities must act now to curb this growing epidemic.
Tobacco use remains a primary driver of non-communicable diseases (NCDs) nationwide. Specifically, the Ministry of Health attributes approximately 13 lakh annual deaths to tobacco-related complications. These include cardiovascular diseases, respiratory illnesses, and various cancers. Furthermore, the rising incidence of tobacco use among poorer households places an immense strain on the state’s healthcare budget. Schemes like Ayushman Bharat bear the brunt of these preventable chronic conditions. Thus, addressing consumption is vital for safeguarding the nation's human capital.
The EAC-PM suggests a multi-pronged strategy to reduce consumption levels effectively. First, the paper recommends rationalizing and strengthening taxation across all tobacco products. While a 100% levy on chewing tobacco is a strong step, fiscal measures alone may not suffice. Second, the government should tighten enforcement against illicit and surrogate sales. Moreover, integrating preventive counseling within primary healthcare systems can provide crucial support for those wishing to quit. By expanding awareness campaigns, the state can better protect vulnerable populations from addictive products.
Q1: Which tobacco products are most popular in urban Indian households?
Cigarettes are the most common tobacco product in cities, used by 18.1% of urban households. Gutkha follows closely, with a 16.8% usage rate among city dwellers.
Q2: How much has tobacco expenditure increased in recent years?
Per capita spending on tobacco rose sharply by 58% in rural India and 77% in urban areas between 2011-12 and 2023-24.
Q3: What are the main recommendations of the EAC-PM working paper?
The paper suggests rationalizing tobacco taxes, tightening enforcement against illicit sales, expanding awareness campaigns, and integrating preventive counseling in primary care.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


EAC-PM warns of rising tobacco consumption in India, urging higher taxes and healthcare integration to protect public health and fiscal sustainability....
7 months ago

Novel diimide and hydrazone scaffolds, particularly compound #C4, synergistically reactivate latent HIV-1 when combined with JQ1 or PKC activators. Demonstrating donor-matched proviral transcription ex vivo and non-canonical signaling, these findings advance shock and kill strategies toward reservoir eradication.
Today

A cross-sectional study reveals that maternal RSV vaccination coverage reached only 43.7% in Argentina, with maternal vaccine knowledge being the sole independent predictor of uptake. Clinicians play a crucial role in eliminating informational and structural barriers to optimize infant health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday